You are here

  • Home
  • Archive
  • Volume 68, Issue 10
  • Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer

Article metrics

Article menu
Original article
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer

 

Online download statistics by month:

Online download statistics by month: August 2015 to September 2024

AbstractFullPdf
Aug 2015160120209
Sep 20153819355
Oct 20152544037
Nov 20151202430
Dec 201598258
Jan 20161132826
Feb 2016481614
Mar 201633814
Apr 201630817
May 20164378
Jun 201640519
Jul 2016321317
Aug 201621711
Sep 201631812
Oct 20162115
Nov 201632116
Dec 20161156
Jan 20172179
Feb 2017189
Mar 20170205
Apr 201712510
May 20170304
Jun 20176217
Jul 201719194
Aug 201731318
Sep 2017262412
Oct 201718184
Nov 201727278
Dec 201716168
Jan 201821212
Feb 201816147
Mar 201822238
Apr 20181831848
May 201861622
Jun 201857575
Jul 201844395
Aug 201886862
Sep 2018676722
Oct 201868689
Nov 20181521526
Dec 20181361361
Jan 20191101056
Feb 20191091105
Mar 201946459
Apr 20191192
May 2019121211
Jun 2019544
Jul 20191084
Aug 2019448
Sep 2019444
Oct 201912135
Nov 2019766
Dec 201911106
Jan 202020156
Feb 2020888
Mar 202015154
Apr 2020763
May 202014131
Jun 202014112
Jul 202023208
Aug 2020776
Sep 202013135
Oct 2020987
Nov 20201379
Dec 20201096
Jan 202121158
Feb 2021559
Mar 2021973
Apr 202113116
May 2021776
Jun 202110106
Jul 2021448
Aug 2021659
Sep 202112124
Oct 202113919
Nov 20217724
Dec 2021977
Jan 2022121110
Feb 202213139
Mar 2022884
Apr 202216166
May 202227279
Jun 202226267
Jul 202221183
Aug 202227246
Sep 202221227
Oct 2022535212
Nov 2022171710
Dec 2022383310
Jan 202312134
Feb 202330306
Mar 202310611
Apr 2023447
May 20231279
Jun 202321125
Jul 2023989
Aug 2023261514
Sep 2023833
Oct 202383765
Nov 20231541546
Dec 2023292314
Jan 2024131310
Feb 2024777
Mar 2024559
Apr 202412139
May 2024151110
Jun 202418136
Jul 2024363010
Aug 2024394212
Sep 2024151210
Total399428991172